Literature DB >> 19087127

CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease.

D Bulut1, H Tüns, A Mügge.   

Abstract

BACKGROUND: First-degree relatives of patients with premature coronary artery disease (CAD) develop endothelial dysfunction even in the case they are apparently healthy. In this study we wanted to clarify whether reduced blood levels of circulating endothelial progenitor cells (EPCs), an endogenous repair mechanism to replace dysfunctional endothelium, or elevated endothelial-derived microparticles (EMPs), an indicator and a mediator of increased endothelial cell damage/apoptosis, are an initial step in the pathogenesis of endothelial dysfunction in genetically predisposed subjects.
MATERIALS AND METHODS: Fifty-six healthy young men (aged 23 to 31 years) from a fire brigade were enrolled, of which 20 subjects had a positive family history (FH) for premature CAD. Subjects with or without a positive FH did not differ with respect to age, body mass index, risk factors and C-reactive protein. Endothelial function was assessed by hyperaemia-mediated relaxation of the brachial artery, blood levels of EPCs (VEGFR2(+)CD34(+) cells) and number of EMPs (CD31(+(bright))/Annexin V(+) particles) were analysed by flow cytometry.
RESULTS: Hyperaemia-mediated relaxation of the brachial artery was similar in both groups, and the blood levels of EPCs were comparable. However, the number of EMPs were significantly increased in subjects with a positive FH compared to those with a negative FH (neg. FH: 55.31 +/- 4.88 vs. pos. FH: 70.37 +/- 6.32 particles microL(-1 )platelet poor plasma; P < 0.05). Number of EMPs correlate inversely with the FMD response.
CONCLUSIONS: These results suggest that increased plasma levels of EMPs may be an initial step in the development of endothelial dysfunction in genetically predisposed subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19087127     DOI: 10.1111/j.1365-2362.2008.02058.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

Review 1.  Endothelial dysfunction: its clinical value and methods of assessment.

Authors:  Teresa Strisciuglio; Stefania De Luca; Ernesto Capuano; Rossella Luciano; Tullio Niglio; Bruno Trimarco; Gennaro Galasso
Journal:  Curr Atheroscler Rep       Date:  2014-06       Impact factor: 5.113

2.  Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers.

Authors:  Cynthia Gordon; Kirana Gudi; Anja Krause; Rachel Sackrowitz; Ben-Gary Harvey; Yael Strulovici-Barel; Jason G Mezey; Ronald G Crystal
Journal:  Am J Respir Crit Care Med       Date:  2011-03-11       Impact factor: 21.405

3.  Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.

Authors:  Daniel Bulut; Michael Scheeler; Lisa Marie Niedballa; Thomas Miebach; Andreas Mügge
Journal:  Clin Res Cardiol       Date:  2011-02-06       Impact factor: 5.460

Review 4.  Microparticles and microRNAs: new players in the complex field of coagulation.

Authors:  Claudia Camaioni; Massimo Gustapane; Pio Cialdella; Roberta Della Bona; Luigi Marzio Biasucci
Journal:  Intern Emerg Med       Date:  2011-10-28       Impact factor: 3.397

Review 5.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

6.  Apoptosis in esophagus and pancreas carcinoma cells induced by circulating microparticles is related to phosphatidyl serine and microparticle-associated caspases.

Authors:  Jan Schneider; Ansgar M Chromik; Waldemar Uhl; Andreas Mügge; Daniel Bulut
Journal:  Med Oncol       Date:  2011-03-31       Impact factor: 3.064

7.  Levels of circulating endothelial cells and colony-forming units are influenced by age and dyslipidemia.

Authors:  Francesca I Fabbri-Arrigoni; Lindsey Clarke; Guosu Wang; Marietta Charakida; Elizabeth Ellins; Neil Halliday; Paul A Brogan; John E Deanfield; Julian P Halcox; Nigel Klein
Journal:  Pediatr Res       Date:  2012-06-12       Impact factor: 3.756

Review 8.  Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

Authors:  Morgane Baron; Chantal M Boulanger; Bart Staels; Anne Tailleux
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

Review 9.  Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation.

Authors:  Henry S Cheng; Makon-Sébastien Njock; Nadiya Khyzha; Lan T Dang; Jason E Fish
Journal:  Front Genet       Date:  2014-12-10       Impact factor: 4.599

10.  Endurance capacity is not correlated with endothelial function in male university students.

Authors:  Yan Wang; Xian-bo Zeng; Feng-juan Yao; Fang Wu; Chen Su; Zhen-guo Fan; Zhu Zhu; Jun Tao; Yi-jun Huang
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.